IGBA Appoints Frittelli As 2022 Chair
Vivian Frittelli Sits As Chair Of IGBA For The Second Time
Executive Summary
The IGBA has appointed Vivian Frittelli as chair of the organization for 2022, taking over from Sudarshan Jain. It is Frittelli’s second time as chair of IGBA, having taken up the mantle the first time following its 2015 rebrand.
You may also be interested in...
IGBA Launches Global Biosimilars Week 2021
The IGBA has followed the success of its inaugural Global Biosimilars Week in November 2020 by launching the second incarnation of the initiative, running this week.
Global Industry Bodies Urge Wider Use Of COVID-19-Related Regulatory Flexibilities
A range of steps have been taken to allow the scale-up of manufacturing of COVID-19 products during the pandemic. Now industry says the use of these flexibilities needs to be expanded to enhance the current pandemic response and rapidly increase product supply.
Off-Patent Industry Must Become ‘Focal Point’ For Health Systems Post-COVID
Off-patent medicines must become the “focal point” of pharmaceutical policies across the world as health systems recover from the COVID-19 pandemic, Medicines for Europe and the IGBA have urged as they held their joint annual conference in Athens, Greece.